Home › Funds › Vestal Point Capital, LP › GLUE

Vestal Point Capital, LP position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

Vestal Point Capital, LP reported holding 4,600,000 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$111.3M, representing 2.60% of its reported portfolio and ranking #13 among its reported holdings. Vestal Point Capital, LP has disclosed GLUE holdings in 7 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)4.60M sh
Reported value held$111.32M
Portfolio Weight2.60%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Vestal Point Capital, LP's GLUE position evolved

Vestal Point Capital, LP first disclosed a stake in GLUE in Q2 2024 at 890,000 shares (US$3.3M). The position peaked in Q2 2026 at 4,600,000 shares, worth US$111.3M. Across 7 filings, Vestal Point Capital, LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 4,600,000 shares valued at US$111.3M — an increase of 996,535 shares quarter over quarter.. Notable position changes include a 54% trim in Q4 2024 (shares fell 33% over the following quarter), a 365% increase in Q1 2026 (shares rose 47% over the following quarter), a 28% increase in Q2 2026 (shares fell 51% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 890.00K $3.33M New
Q3 2024 930.00K $4.93M Add
Q4 2024 425.00K $2.95M Reduce
Q3 2025 800.00K $5.93M New
Q4 2025 775.00K $12.15M Reduce
Q1 2026 3.60M $59.28M Add
Q2 2026 4.60M $111.32M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), BVF INC/IL (US$108.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has Vestal Point Capital, LP held GLUE?

Vestal Point Capital, LP has disclosed GLUE holdings in 7 of the last 9 reported quarters, going back to Q2 2024.

What is Vestal Point Capital, LP's current position in GLUE?

As of Q2 2026, Vestal Point Capital, LP holds 4.60M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $111.32M, representing 2.60% of its reported portfolio and ranking #13.

Has Vestal Point Capital, LP been buying or selling GLUE?

In the latest 13F filing (Q2 2026), Vestal Point Capital, LP increased its position in GLUE. The position peaked in Q2 2026 at 4.60M shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, BVF INC/IL, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.